Showing results (91-100 of 250) with videos related to

Sort By:
Pageof 25
Melanoma Research|January 3, 2019
Prognostic significance of distant metastasis-free interval in patients with relapsed melanoma treated with BRAF with or without MEK inhibitorsDimitrios Bafaloukos, George Papaxoinis, Helena Linardou, et al.
Melanoma Research|August 12, 2004
The effect of temozolomide-based chemotherapy in patients with cerebral metastases from melanomaDimitros Bafaloukos, Dimosthenis Tsoutsos, Georges Fountzilas, et al.
Critical Reviews in Oncology/Hematology|January 31, 2025
Clinical benefit of immune checkpoint inhibitors in elderly cancer patients: Current evidence from immunosenescence pathophysiology to clinical trial resultsDimitrios C Ziogas, Charalampos Theocharopoulos, Katerina Aravantinou, et al.
Breast Cancer Research and Treatment|December 3, 2005
Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 womenGeorge Pentheroudakis, George Fountzilas, Dimitrios Bafaloukos, et al.
Current Oncology Reports|July 10, 2026
Infectious Complications of Antibody-Drug Conjugates: A Review of Safety Data from FDA-Approved AgentsGeorgios Schinas, Pantazis-Michael Voutsinas, Dimitra Stefanou, et al.
Cancer Treatment Reviews|November 26, 2010
Methods of detection of circulating melanoma cells: a comparative overviewAndrianos Nezos, Pavlos Msaouel, Nikolaos Pissimissis, et al.
Oncology|March 6, 2009
Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluationChristos Christodoulou, Ioannis Kostopoulos, Haralabos P Kalofonos, et al.
Anticancer Research|July 15, 2009
Cisplatin-Ifosfamide-gemcitabine as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and PaclitaxelAristides Polyzos, Nikolas Tsavaris, Helen Gogas, et al.
Breast Cancer Research : BCR|June 18, 2009
Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudyChristos Markopoulos, Urania Dafni, John Misitzis, et al.
Plos One|August 23, 2012
A multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferonEna Wang, Yingdong Zhao, Alessandro Monaco, et al.
Pageof 25